Center-Authored Papers

Filters: Author is Southey, Melissa C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Kote-Jarai Z, Al Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H et al..  2011.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.. Nature genetics. 43(8):785-791. Abstract
R
Win AK, Buchanan DD, Rosty C, MacInnis RJ, Dowty JG, Dite GS, Giles GG, Southey MC, Young JP, Clendenning M et al..  2015.  Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.. Gut. 64(1):101-10. Abstract
Win AK, Reece JC, Dowty JG, Buchanan DD, Clendenning M, Rosty C, Southey MC, Young JP, Cleary SP, Kim H et al..  2016.  Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.. International journal of cancer. 139(7):1557-1563. Abstract
Al Olama AA, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal D, Hamdy FC, Donovan JL, Muir K, Schleutker J et al..  2015.  Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(19):5589-602. Abstract
P
Szulkin R, Whitington T, Eklund M, Aly M, Eeles RA, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K et al..  2015.  Prediction of individual genetic risk to prostate cancer using a polygenic score.. The Prostate. Abstract
Mavaddat N, Pharoah PDP, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M et al..  2015.  Prediction of breast cancer risk based on profiling with common genetic variants.. Journal of the National Cancer Institute. 107(5) Abstract
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ et al..  2016.  PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.. Journal of medical genetics. Abstract
N
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H et al..  2016.  No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. 141(2):386-401. Abstract
Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, Morrison J, Maranian M, Pooley KA, Luben R et al..  2009.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.. Nature genetics. 41(5):585-90. Abstract
Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KKH, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E et al..  2015.  Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(10):1574-1584. Abstract
M
Al Olama AA, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S et al..  2015.  Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.. Human molecular genetics. 24(19):5589-5602. Abstract
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE et al..  2013.  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.. Nature genetics. 45(4):371-84,384e1-2. Abstract
Parry S, Win AK, Parry B, Macrae FA, Gurrin LC, Church JM, Baron JA, Giles GG, Leggett BA, Winship I et al..  2011.  Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.. Gut. 60(7):950-7. Abstract
Al Olama AA, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC et al..  2013.  A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.. Human molecular genetics. 22(2):408-15. Abstract
Berndt SI, Camp NJ, Skibola CF, Vijai J, Wang Z, Gu J, Nieters A, Kelly RS, Smedby KE, Monnereau A et al..  2016.  Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.. Nature communications. 7:10933. Abstract
L
Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, Sulem P, Bulik-Sullivan B et al..  2015.  Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair--Editorial Comment. Obstetrical & Gynecological Survey. 70(12):758-762.
Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, Sulem P, Bulik-Sullivan B et al..  2015.  Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair.. Nature genetics. 47(11):1294-1303. Abstract
I
Wang Z, Zhu B, Zhang M, Parikh H, Jia J, Chung CC, Sampson JN, Hoskins JW, Hutchinson A, Burdette L et al..  2014.  Imputation and subset based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.. Human molecular genetics. 23(24):6616-33. Abstract
Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA et al..  2009.  Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.. Nature genetics. 41(10):1116-21. Abstract
Eeles RA, Al Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S et al..  2013.  Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.. Nature genetics. 45(4):385-91,391e1-2. Abstract
Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G et al..  2017.  Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.. Nature genetics. Abstract
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin H-Y, Chen AY, Tsai Y-Y, Qu X et al..  2013.  Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.. Nature communications. 4:1627. Abstract
H
Lophatananon A, Stewart-Brown S, Kote-Jarai Z, Al Olama AA, Benlloch Garcia S, Neal DE, Hamdy FC, Donovan JL, Giles GG, Fitzgerald LM et al..  2017.  Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.. British journal of cancer. Abstract
Zhang B, Shu X-O, Delahanty RJ, Zeng C, Michailidou K, Bolla MK, Wang Q, Dennis J, Wen W, Long J et al..  2015.  Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.. Journal of the National Cancer Institute. 107(11) Abstract
G
Pharoah PDP, Tsai Y-Y, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H et al..  2013.  GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.. Nature genetics. 45(4):362-70,370e1-2. Abstract